DarioHealth Corp. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- DarioHealth Corp. stock issued during period, value, new issues for the quarter ending 2025-12-31 was -$19.00K.
- DarioHealth Corp. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $17.39M.
- DarioHealth Corp. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- DarioHealth Corp. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- DarioHealth Corp. stock issued during period, value, new issues for fiscal 2025 was $17.37M.
- DarioHealth Corp. stock issued during period, value, new issues for fiscal 2018 was $0.00.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $17.37M 10-K · filed 2026-03-19 |
| 2025-09-30 | $17.39M 10-Q · filed 2025-11-13 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | |
| 2024-03-31 | $20.21M 10-Q · filed 2024-05-15 | |
| 2023-09-30 | $204.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $16.28M 10-Q · filed 2024-08-08 | |
| 2021-03-31 | $28.93M 10-Q · filed 2021-05-17 | |
| 2019-06-30 | $6.56M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | -$6.33M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $0.00 10-K · filed 2020-03-17 |
| 2018-09-30 | $3.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $13.92M derived: sum of 4 quarters · filed 2018-11-13 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | |
| 2018-03-31 | $2.87M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $7.59M derived: 10-Q 12 month − 10-Q 9 month · filed 2018-11-13 | $9.47M 10-Q · filed 2018-11-13 |
| 2016-12-31 | -$3.47M derived: 10-Q 12 month − 10-Q 9 month · filed 2018-03-19 | $1.57M 10-Q · filed 2018-03-19 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | |
| 2016-03-31 | $5.04M 10-Q · filed 2016-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |